Antibody Responsiveness to Influenza: What Drives It?

Antibody Responsiveness to Influenza: What Drives It?

The induction of a specific antibody response has long been accepted as a serological hallmark of recent infection or antigen exposure. Much of our understanding of the influenza antibody response has been derived from studying antibodies that target the hemagglutinin (HA) protein. However, growing...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Xia Lin, Fangmei Lin, Tingting Liang, Mariette F. Ducatez, Mark Zanin, Sook-San Wong
Format:	Artikel
Sprache:	English
Veröffentlicht:	MDPI AG 2021-07-01
Schriftenreihe:	Viruses
Schlagworte:	influenza antibody responses seroconversion immunity vaccine
Online Zugang:	https://www.mdpi.com/1999-4915/13/7/1400

Ähnliche Einträge

Activated CD4+ T cells and CD14hiCD16+ monocytes correlate with antibody response following influenza virus infection in humans
von: Sook-San Wong, et al.
Veröffentlicht: (2021-04-01)

Predictor Factors Affecting Seroconversion Post-Influenza Vaccination in the Elderly
von: Saskia Aziza Nursyirwan, et al.
Veröffentlicht: (2017-12-01)

Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil
von: Artur Capão, et al.
Veröffentlicht: (2022-07-01)

Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies
von: Rachael Keating, et al.
Veröffentlicht: (2020-12-01)

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
von: Deniz C. Guven, et al.
Veröffentlicht: (2021-11-01)

Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity
von: Jocelyn G. Labombarde, et al.
Veröffentlicht: (2022-03-01)

Correlation of Frailty Status with Influenza Vaccine Seroconversion and Seroprotection among Elderly Population
von: Sukamto Koesnoe, et al.
Veröffentlicht: (2016-12-01)

Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis Patients
von: Jaromír Eiselt, et al.
Veröffentlicht: (2016-02-01)

Anti-Hepatitis B Antibody Levels In Immunized Medical Students: Are They At Risk?
von: Keila Zaniboni Siqueira Batista, et al.
Veröffentlicht: (2019-05-01)

Female Antibodies Go the Distance against Influenza Viruses
von: Marina R. Good, et al.
Veröffentlicht: (2022-10-01)

Study of Antibodies to Influenza Neuraminidase N2
von: Yulia Desheva, et al.
Veröffentlicht: (2022-04-01)

Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure
von: Vipin Narang, et al.
Veröffentlicht: (2018-10-01)

Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study
von: Shaohuan Wu, et al.
Veröffentlicht: (2022-11-01)

The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials
von: Yeh TL, et al.
Veröffentlicht: (2018-01-01)

Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza
von: Csaba Laszlofy, et al.
Veröffentlicht: (2024-03-01)

Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients
von: Moon Sung Jin, et al.
Veröffentlicht: (2012-12-01)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
von: Saranya Sridhar, et al.
Veröffentlicht: (2015-04-01)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
von: Nada Abbadi, et al.
Veröffentlicht: (2023-01-01)

Influenza A(H5N2) Virus Antibodies in Humans after Contact with Infected Poultry, Taiwan, 2012
von: Ho-Sheng Wu, et al.
Veröffentlicht: (2014-05-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
von: Kaori Sano, et al.
Veröffentlicht: (2018-08-01)

Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies
von: Marwa Abd Alhadi, et al.
Veröffentlicht: (2023-06-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
von: Sabari Nath Neerukonda, et al.
Veröffentlicht: (2020-07-01)

Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies
von: Xiao-Zheng Li, et al.
Veröffentlicht: (2024-12-01)

Factors Associated with Dog Rabies Immunization in Changsha, China: Results of a Cross-Sectional Cluster Survey, 2015–2021
von: Chunxiao Ji, et al.
Veröffentlicht: (2022-12-01)

Follow-Up of PRRSv-Vaccinated Piglets Born from PRRSv-Vaccinated, ELISA-Seropositive and ELISA-Seronegative Sows
von: Jorian Fiers, et al.
Veröffentlicht: (2023-02-01)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
von: Mariia V. Sergeeva, et al.
Veröffentlicht: (2023-11-01)

Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults
von: Chris P. Verschoor, et al.
Veröffentlicht: (2021-01-01)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
von: E. R. Job, et al.
Veröffentlicht: (2019-10-01)

Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine
von: Lukas Hoen, et al.
Veröffentlicht: (2024-08-01)

B cells and functional antibody responses to combat influenza
von: Giuseppe eLofano, et al.
Veröffentlicht: (2015-06-01)

T cell immunity to influenza in older adults: A pathophysiological framework for development of more effective vaccines
von: Janet E McElhaney, et al.
Veröffentlicht: (2016-02-01)

Experimental Infection of Horses with Influenza D Virus
von: Chithra C. Sreenivasan, et al.
Veröffentlicht: (2022-03-01)

SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
von: S. A. Donina, et al.
Veröffentlicht: (2014-07-01)

Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine
von: Christopher E. Lopez, et al.
Veröffentlicht: (2020-08-01)

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
von: Eun Hye Kim, et al.
Veröffentlicht: (2017-08-01)

Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study
von: Kunal Kumar, et al.
Veröffentlicht: (2024-03-01)

ТHE LEVEL OF ANTIBODIES TO THE INFLUENZA VIRUS IN PREGNANT WOMEN VACCINATED WITH SUBUNIT VACCINE
von: M. P. Kostinov, et al.
Veröffentlicht: (2018-01-01)

Anti-neuraminidase immunity in the combat against influenza
von: Xiaojian Zhang, et al.
Veröffentlicht: (2024-12-01)

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
von: Alyse D. Portnoff, et al.
Veröffentlicht: (2020-02-01)

Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff
von: M. P. Kostinov, et al.
Veröffentlicht: (2025-01-01)